178 related articles for article (PubMed ID: 36238770)
1. Inflammation-Based Scores Predict Responses to PD-1 Inhibitor Treatment in Intrahepatic Cholangiocarcinoma.
Yang Z; Zhang D; Zeng H; Fu Y; Hu Z; Pan Y; Chen J; Wang J; Zhang Y; Zhou Z; Xu L; Hu D; Chen M
J Inflamm Res; 2022; 15():5721-5731. PubMed ID: 36238770
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the Prognostic Value of Inflammation-Based Scores in Patients with Hepatocellular Carcinoma After Anti-PD-1 Therapy.
Mei J; Sun XQ; Lin WP; Li SH; Lu LH; Zou JW; Wei W; Guo RP
J Inflamm Res; 2021; 14():3879-3890. PubMed ID: 34408469
[TBL] [Abstract][Full Text] [Related]
3. Comparative performance of inflammation-based prognostic scores in patients operated for intrahepatic cholangiocarcinoma.
Lin J; Fang T; Zhu M; Xu X; Zhang J; Zheng S; Jing C; Zhang M; Liu B; Zhang B
Cancer Manag Res; 2019; 11():9107-9119. PubMed ID: 31802940
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the prognostic value of inflammation-based scores in early recurrent hepatocellular carcinoma after hepatectomy.
Wang C; He W; Yuan Y; Zhang Y; Li K; Zou R; Liao Y; Liu W; Yang Z; Zuo D; Qiu J; Zheng Y; Li B; Yuan Y
Liver Int; 2020 Jan; 40(1):229-239. PubMed ID: 31652394
[TBL] [Abstract][Full Text] [Related]
5. The Predictive Value of Preoperative High-Sensitive C-Reactive Protein/Albumin Ratio in Systemic Inflammatory Response Syndrome After Percutaneous Nephrolithotomy.
Xu H; Hu L; Wei X; Niu J; Gao Y; He J; Hou J
J Endourol; 2019 Jan; 33(1):1-8. PubMed ID: 30430854
[TBL] [Abstract][Full Text] [Related]
6. Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101.
He CB; Lin XJ
PLoS One; 2017; 12(3):e0174769. PubMed ID: 28355305
[TBL] [Abstract][Full Text] [Related]
7. Utility of prognostic nutritional index and systemic immune-inflammation index in oral cancer treatment.
Kubota K; Ito R; Narita N; Tanaka Y; Furudate K; Akiyama N; Chih CH; Komatsu S; Kobayashi W
BMC Cancer; 2022 Apr; 22(1):368. PubMed ID: 35392843
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Value of Inflammation Biomarkers for Survival of Patients with Neuroblastoma.
Zheng C; Liu S; Feng J; Zhao X
Cancer Manag Res; 2020; 12():2415-2425. PubMed ID: 32280277
[TBL] [Abstract][Full Text] [Related]
9. Clinical implications of six inflammatory biomarkers as prognostic indicators in Ewing sarcoma.
Li YJ; Yang X; Zhang WB; Yi C; Wang F; Li P
Cancer Manag Res; 2017; 9():443-451. PubMed ID: 29033609
[TBL] [Abstract][Full Text] [Related]
10. The Relationship Between Preoperative Systemic Immune Inflammation Index and Prognostic Nutritional Index and the Prognosis of Patients With Alveolar Hydatid Disease.
Ren B; Chen X; Lei P; Hou L; Wang H; Zhou Y; Ren L; Fan H; Wang Z; Yuan J
Front Immunol; 2021; 12():691364. PubMed ID: 34248983
[TBL] [Abstract][Full Text] [Related]
11. Levels of pretreatment serum lipids predict responses to PD-1 inhibitor treatment in advanced intrahepatic cholangiocarcinoma.
Yang Z; Zhang D; Sima X; Fu Y; Zeng H; Hu Z; Hou J; Pan Y; Zhang Y; Zhou Z; Chen M; Hu D
Int Immunopharmacol; 2023 Feb; 115():109687. PubMed ID: 36628893
[TBL] [Abstract][Full Text] [Related]
12. Comparison of inflammation-based prognostic scores as predictors of survival outcomes in patients with germ cell tumors.
Yoshinaga K; Sadahira T; Maruyama Y; Mitsui Y; Iwata T; Wada K; Araki M; Watanabe T; Nasu Y
Investig Clin Urol; 2021 Jan; 62(1):47-55. PubMed ID: 33314803
[TBL] [Abstract][Full Text] [Related]
13. Investigating effects of preoperative inflammatory biomarkers on predicting survival outcomes of intrahepatic cholangiocarcinoma after curative resection.
Zhang Z; Zhou Y; Hu K; Huang Y
World J Surg Oncol; 2020 Oct; 18(1):272. PubMed ID: 33097053
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of the lymphocyte-to-monocyte ratio in patients with malignant pleural mesothelioma.
Yamagishi T; Fujimoto N; Nishi H; Miyamoto Y; Hara N; Asano M; Fuchimoto Y; Wada S; Kitamura K; Ozaki S; Kishimoto T
Lung Cancer; 2015 Oct; 90(1):111-7. PubMed ID: 26259877
[TBL] [Abstract][Full Text] [Related]
15. [The Predictive Value of Perioperative Inflammatory Indicatorsin Prognosis of the Intrahepatic Cholangiocarcinoma Patients after Hepatectomy].
Zhang ZF; Wang T; Kong JJ; Yang LP; Yang XW; Wang WT
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):403-410. PubMed ID: 32543151
[TBL] [Abstract][Full Text] [Related]
16. Preoperative Systemic Immune-Inflammation Index (SII) as a Superior Predictor of Long-Term Survival Outcome in Patients With Stage I-II Gastric Cancer After Radical Surgery.
He K; Si L; Pan X; Sun L; Wang Y; Lu J; Wang X
Front Oncol; 2022; 12():829689. PubMed ID: 35296020
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of inflammation-based scores in patients with ampullary carcinoma after pancreaticoduodenectomy.
Sun S; He C; Wang J; Huang X; Wu J; Li S
BMC Cancer; 2020 Oct; 20(1):981. PubMed ID: 33036573
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer.
Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J
BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein/albumin ratio as prognostic score in oral squamous cell carcinoma.
Park HC; Kim MY; Kim CH
J Korean Assoc Oral Maxillofac Surg; 2016 Oct; 42(5):243-250. PubMed ID: 27847731
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of the C-reactive protein to albumin ratio: a novel inflammation-based prognostic indicator in osteosarcoma.
Li YJ; Yao K; Lu MX; Zhang WB; Xiao C; Tu CQ
Onco Targets Ther; 2017; 10():5255-5261. PubMed ID: 29138578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
